Covax endorsed AstraZeneca’s jab on Thursday as it celebrated shipping coronavirus vaccine doses to 100 different regions around the world.
AstraZeneca’s Covid-19 vaccine accounts for almost the entire first wave of doses distributed through the facility, giving 92 poorest countries free access to jabs.
However, the program was delayed after New Delhi put a brake on exports from the Serum Institute of India factory to combat the second wave of Covid-19 infection.
SII is one of two sites that manufacture AstraZeneca doses of Covax. The other is South Korea.
The first wave of Covax was aimed at distributing approximately 238.2 million doses to 142 participating countries by May 31st.
Of these, 237 million are AstraZeneca doses and 1.2 million are Pfizer / BioNTech.
AstraZeneca’s vaccine has been completely banned in some countries because of fear of blood clots, and many countries have stopped using the vaccine for young people.
EU drug regulators said on Wednesday that blood clots should be listed as a rare side effect of AstraZeneca jab, emphasizing that benefits continue to outweigh risks.
A World Health Organization vaccination expert said the causality was “believed to be plausible but unconfirmed,” adding that the reported outbreaks were “very rare.”
The balance between risk and benefit remains “very good for vaccines,” WHO told AFP.
Covax is co-led by WHO, the Gavi Vaccine Alliance, and the Infectious Disease Control Innovation Alliance.
Gavi said safety and effectiveness are “Covax’s top priorities.”
The plan follows WHO’s guidance on “unchanged” vaccine products for AstraZeneca’s jabs, a Gavi spokeswoman told AFP.
“The AstraZeneca vaccine remains an important public health tool for the Covid-19 pandemic and is effective in preventing severe cases, hospitalizations and deaths.”
Delivery to Saint Lucia in the Caribbean has reached the milestone of the 100th country.
Forty-two days after the first cargo landed in Ghana on February 24, Ghana’s President Nana Akufo-Ad took the first shot publicly.
To date, doses of approximately 38.4 million have been delivered to 102 regions, including 61 of the 92 poorest participating countries whose funding is covered by donors.
“Covax hopes to provide doses to all participating countries that have requested the vaccine earlier this year,” Gavi said in a statement.
This was due to “despite reduced availability in March and April” due to manufacturers tweaking their production processes, and “increasing demand for Covid-19 vaccine in India.” Stated.
Some of the world’s largest countries have received vaccines to date, including India, Indonesia, Brazil, Nigeria, Ethiopia, the Philippines, Egypt, Vietnam, the Democratic Republic of the Congo and Iran.
The smallest deliveries were Tuvalu, Nauru, the Pacific Islands of Tonga, Dominica in the Caribbean, and Andorra, a small European country.
Six G20 countries, Argentina, Brazil, Canada, Indonesia, Saudi Arabia and South Korea, are receiving doses.
Delivery has also reached Yemen and Afghanistan, which the United Nations claims are at the worst humanitarian crisis in the world.
“As we are ending the acute phase of the pandemic, we are still facing challenges,” said Seth Berkley, Gavi’s CEO.
“It’s not a time of complacency, as we continue to deploy the largest and fastest global vaccine in history.”
The plan aims to distribute sufficient doses to vaccinate up to 27 percent of the population of 92 poorest participating countries by the end of the year.
In 2021, an additional $ 2 billion will be needed to cover and secure up to 1.8 billion donor-funded vaccine doses in these regions.
German Foreign Minister Heiko Maas warned that the Saint Lucian milestone “give us hope, but access to vaccines, medicines and tests should not be a geopolitical pawn.”
WHO Chief Tedros Adhanom Ghebreyesus has regularly blown up rich countries to monopolize vaccine batches while poor countries are waiting for their first dose.
According to AFP counts, more than 710 million Covid-19 vaccines have been administered worldwide in at least 195 regions around the world.
However, WHO Africa Regional Director Matshidiso Moeti said that only 2 percent of these doses were administered on the African continent.
“More than a billion Africans remain at the end of this historic procession to end this pandemic,” she said.
Covax Backs AstraZeneca As Vaccines Reach 100 Territories Source link Covax Backs AstraZeneca As Vaccines Reach 100 Territories